Related references
Note: Only part of the references are listed.Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations
Hsuan-Ping Chang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2021)
A Two-Pore Physiologically Based Pharmacokinetic Model to Predict Subcutaneously Administered Different-Size Antibody/Antibody Fragments
Zhe Li et al.
AAPS JOURNAL (2021)
Antibody Format and Serum Disposition Govern Ocular Pharmacokinetics of Intravenously Administered Protein Therapeutics
Vittal Shivva et al.
FRONTIERS IN PHARMACOLOGY (2021)
Two-pore physiologically based pharmacokinetic model validation using whole-body biodistribution of trastuzumab and different-size fragments in mice
Zhe Li et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2021)
Imaging Reveals Importance of Shape and Flexibility for Glomerular Filtration of Biologics
Hanine Rafidi et al.
MOLECULAR CANCER THERAPEUTICS (2021)
The Production, Quality Control, and Characterization of ZED8, a CD8-Specific 89Zr-Labeled Immuno-PET Clinical Imaging Agent
Herman Gill et al.
AAPS JOURNAL (2020)
Light-Induced Radiosynthesis of Zr-89-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor
Simon Klingler et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Mechanistic Quantitative Pharmacology Strategies for the Early Clinical Development of Bispecific Antibodies in Oncology
Alison Betts et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Two-pore physiologically based pharmacokinetic model with de novo derived parameters for predicting plasma PK of different size protein therapeutics
Zhe Li et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)
Photoradiosynthesis of 68Ga-Labeled HBED-CC-Azepin-MetMAb for Immuno-PET of c-MET Receptors
Rachael Fay et al.
BIOCONJUGATE CHEMISTRY (2019)
Effect of Size on Solid Tumor Disposition of Protein Therapeutics
Zhe Li et al.
DRUG METABOLISM AND DISPOSITION (2019)
Impact of polymer geometry on the interactions of protein-PEG conjugates
Jonathan Zarzar et al.
BIOPHYSICAL CHEMISTRY (2018)
Relative Target Affinities of T-Cell-Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
Danielle Mandikian et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications
Ruisi Fu et al.
CHEMMEDCHEM (2018)
Structure and Distribution of an Unrecognized Interstitium in Human Tissues
Petros C. Benias et al.
SCIENTIFIC REPORTS (2018)
Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology
Danielle Mandikian et al.
AAPS JOURNAL (2018)
Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches
Miro J. Eigenmann et al.
JOURNAL OF PHYSIOLOGY-LONDON (2017)
Quantification of IgG monoclonal antibody clearance in tissues
Miro J. Eigenmann et al.
MABS (2017)
The making of bispecific antibodies
Ulrich Brinkmann et al.
MABS (2017)
Influence of Molecular size on the clearance of antibody fragments
Zhe Li et al.
PHARMACEUTICAL RESEARCH (2017)
Pharmacokinetics of Monoclonal Antibodies
Josiah T. Ryman et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2017)
Influence of molecular size on tissue distribution of antibody fragments
Zhe Li et al.
MABS (2016)
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients
Mattias Sandstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Physiology of the Renal Interstitium
Michael Zeisberg et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with 44Sc-Labeled Cetuximab Fab Fragment
Rubel Chakravarty et al.
BIOCONJUGATE CHEMISTRY (2014)
Glypican-3-Targeting F(ab ')2 for Zr-89 PET of Hepatocellular Carcinoma
Jonathan G. Sham et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
The effect of the neonatal Fc receptor on human IgG biodistribution in mice
Nancy Chen et al.
MABS (2014)
Quantitative cumulative biodistribution of antibodies in mice
Victor Yip et al.
MABS (2014)
Enhanced Tumor Retention of a Radiohalogen Label for Site-Specific Modification of Antibodies
C. Andrew Boswell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthesis, Preclinical Validation, Dosimetry, and Toxicity of 68Ga-NOTA-Anti-HER2 Nanobodies for iPET Imaging of HER2 Receptor Expression in Cancer
Catarina Xavier et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Effects of altered FcγR binding on antibody pharmacokinetics in cynomolgus monkeys
Maya K. Leabman et al.
MABS (2013)
Antibody biodistribution coefficients Inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human
Dhaval K. Shah et al.
MABS (2013)
Phase I trial of intraoperative detection of tumor margins in patients with HER2-positive carcinoma of the breast following administration of 111In-DTPA-trastuzumab Fab fragments
Claire M. B. Holloway et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
Mark Merchant et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Compartmental Tissue Distribution of Antibody Therapeutics: Experimental Approaches and Interpretations
C. Andrew Boswell et al.
AAPS JOURNAL (2012)
Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in mice
Daniela Bumbaca et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Differential Effects of Predosing on Tumor and Tissue Uptake of an 111In-Labeled Anti-TENB2 Antibody-Drug Conjugate
C. Andrew Boswell et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Effects of Anti-VEGF on Pharmacokinetics, Biodistribution, and Tumor Penetration of Trastuzumab in a Preclinical Breast Cancer Model
Cinthia V. Pastuskovas et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Optimization of IGF-1R SPECT/CT Imaging Using 111In-Labeled F(ab′)2 and Fab Fragments of Article the Monoclonal Antibody R1507
Sandra Heskamp et al.
MOLECULAR PHARMACEUTICS (2012)
ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging
Tove Olafsen et al.
TUMOR BIOLOGY (2012)
Effects of Anti-VEGF on Predicted Antibody Biodistribution: Roles of Vascular Volume, Interstitial Volume, and Blood Flow
C. Andrew Boswell et al.
PLOS ONE (2011)
Biodistribution Mechanisms of Therapeutic Monoclonal Antibodies in Health and Disease
Mohammad Tabrizi et al.
AAPS JOURNAL (2010)
Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics
C. Andrew Boswell et al.
BIOCONJUGATE CHEMISTRY (2010)
Enhancement of DNA Uptake in FUT8-Deleted CHO Cells for Transient Production of Afucosylated Antibodies
Athena W. Wong et al.
BIOTECHNOLOGY AND BIOENGINEERING (2010)
Renal Toxicity of Radiolabeled Peptides and Antibody Fragments: Mechanisms, Impact on Radionuclide Therapy, and Strategies for Prevention
Erik Vegt et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Development and Evaluation of a Novel Method for Preclinical Measurement of Tissue Vascular Volume
C. Andrew Boswell et al.
MOLECULAR PHARMACEUTICS (2010)
Paradoxical glomerular filtration of carbon nanotubes
Alessandro Ruggiero et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Interstitial fluid: the overlooked component of the tumor microenvironment?
Helge Wiig et al.
FIBROGENESIS & TISSUE REPAIR (2010)
A modeling analysis of the effects of molecular size and binding affinity on tumor targeting
Michael M. Schmidt et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Non-Invasive Imaging of Acute Renal Allograft Rejection in Rats Using Small Animal 18F-FDG-PET
Stefan Reuter et al.
PLOS ONE (2009)
Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
W. Wang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Aquaporin-4-deficient mice have increased extracellular space without tortuosity change
Xiaoming Yao et al.
JOURNAL OF NEUROSCIENCE (2008)
Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: A novel anti-epidermal growth factor receptor antibody
Rushika M. Perera et al.
NEOPLASIA (2007)
Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: Optimal pharmacokinetics for therapy
Vania Kenanova et al.
CANCER RESEARCH (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Elimination mechanisms of therapeutic monoclonal antibodies
MA Tabrizi et al.
DRUG DISCOVERY TODAY (2006)
Antibody pharmacokinetics and pharmacodynamics
ED Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Expression of full-length immunoglobulins in Escherichia coli:: rapid and efficient production of aglycosylated antibodies
LC Simmons et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Metabolism and renal clearance of 111In-labeled DOTA-conjugated antibody fragments
SW Tsai et al.
BIOCONJUGATE CHEMISTRY (2001)
Share Paper
